The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Therapeutic goods regulation
The regulatory framework reflects and upholds the Australian community’s expectations around the safety and quality of therapeutic goods on the market.
-
MAXMAN tablets pose a serious risk to your health and should not be taken.
-
Gold Max Blue capsules pose a serious risk to your health and should not be taken.
-
Dynamint X tablets pose a serious risk to your health and should not be taken.
-
Have your say to help improve the TGA website
Your feedback is essential to shaping a user-friendly website that works better for everyone. -
Recall reforms update and new procedure
Recall reforms program update and preview of the PRAC Version 1.0. -
Our Guidance pages have changed
We have introduced new features to improve your experience using Guidance on our website.
-
This report provides information about our regulatory performance for the 2023-24 financial year.
-
Read our 2024 stakeholder survey report, which aims to improve the way we work with our stakeholders.
-
Communique from the meeting of the TGACC